Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 100 Total
MXCT - MaxCyte Inc - Stock Price Chart
TickerMXCT [NASD, RUT]
CompanyMaxCyte Inc
CountryUSA
IndustryMedical Devices
Market Cap384.10MEPS (ttm)-0.34
P/E-EPS this Y-14.67%
Forward P/E-EPS next Y5.72%
PEG-EPS past 5Y-16.20%
P/S8.45EPS next 5Y-
P/B1.73EPS Q/Q12.16%
Dividend-Sales Q/Q15.33%
Insider Own7.85%Inst Own70.09%
Insider Trans-1.37%Inst Trans0.19%
Short Float3.91%EarningsAug 06/a
Analyst Recom1.25Target Price8.56
Avg Volume384.56K52W Range2.45 - 5.55
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Erck Stanley CDirectorOct 01 '24Option Exercise0.0426,0821,043295,200Oct 02 05:03 PM
Erck Stanley CDirectorOct 02 '24Option Exercise0.0421,607864290,725Oct 02 05:03 PM
Erck Stanley CDirectorOct 01 '24Sale3.7826,08298,590269,118Oct 02 05:03 PM
Erck Stanley CDirectorOct 02 '24Sale3.7121,60780,162269,118Oct 02 05:03 PM
Johnston John JosephDirectorSep 26 '24Option Exercise2.933,0008,778144,950Sep 30 04:15 PM
MMS - Maximus Inc. - Stock Price Chart
TickerMMS [NYSE, RUT]
CompanyMaximus Inc.
CountryUSA
IndustrySpecialty Business Services
Market Cap5.47BEPS (ttm)4.77
P/E19.05EPS this Y60.05%
Forward P/E15.25EPS next Y-2.77%
PEG1.52EPS past 5Y-4.69%
P/S1.04EPS next 5Y12.50%
P/B3.02EPS Q/Q191.57%
Dividend1.32%Sales Q/Q10.62%
Insider Own1.04%Inst Own98.95%
Insider Trans-0.19%Inst Trans2.23%
Short Float1.31%EarningsAug 07/a
Analyst Recom2.00Target Price114.00
Avg Volume393.81K52W Range72.39 - 93.97
MAXIMUS, Inc. engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S. state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions and includes appeals and assessment services, system and application development, IT modernization, and maintenance services. The Outside the U.S segment provides BPS for international governments and commercial clients. The company was founded by David V. Mastran in 1975 and is headquartered in McLean, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Link Michelle F.Chief of Human ResourcesOct 01 '24Sale92.561,363126,1596,567Oct 02 05:02 PM
Link Michelle F.OfficerOct 01 '24Proposed Sale92.561,363126,159Oct 01 12:22 PM
Warren Michael J.DirectorSep 03 '24Buy92.40131,2174,068Sep 10 02:53 PM
Warren Michael J.DirectorMay 31 '24Buy84.97141,2134,055Sep 10 02:53 PM
Warren Michael J.DirectorFeb 29 '24Buy84.0576034,041Sep 10 02:53 PM
CDT - Conduit Pharmaceuticals Inc - Stock Price Chart
TickerCDT [NASD, RUT]
CompanyConduit Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap10.55MEPS (ttm)-0.14
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-32.55%
Dividend-Sales Q/Q-
Insider Own59.28%Inst Own3.05%
Insider Trans-23.93%Inst Trans1.35%
Short Float2.74%Earnings-
Analyst Recom-Target Price-
Avg Volume13.14M52W Range0.09 - 8.75
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nirland Ltd10% OwnerOct 01 '24Sale0.111,250,000141,37510,233,177Oct 02 05:02 PM
Nirland Ltd10% OwnerSep 30 '24Sale0.121,016,823122,01911,483,177Oct 02 05:02 PM
Nirland Ltd10% OwnerOct 02 '24Sale0.10333,17734,2519,900,000Oct 02 05:02 PM
Regan AndrewDirectorJul 16 '24Sale0.3210,244,3923,246,4481,691,727Sep 19 05:01 PM
Regan AndrewDirectorJul 17 '24Sale0.261,514,100391,092177,627Sep 19 05:01 PM
TWST - Twist Bioscience Corp - Stock Price Chart
TickerTWST [NASD, RUT]
CompanyTwist Bioscience Corp
CountryUSA
IndustryDiagnostics & Research
Market Cap2.49BEPS (ttm)-3.81
P/E-EPS this Y4.32%
Forward P/E-EPS next Y30.95%
PEG-EPS past 5Y-6.09%
P/S8.43EPS next 5Y-
P/B5.06EPS Q/Q-46.26%
Dividend-Sales Q/Q27.81%
Insider Own4.26%Inst Own106.40%
Insider Trans-1.66%Inst Trans2.41%
Short Float15.94%EarningsAug 02/b
Analyst Recom1.83Target Price52.20
Avg Volume872.33K52W Range14.42 - 60.90
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green PaulaOfficerOct 02 '24Proposed Sale43.213,310143,027Oct 02 05:01 PM
Cho DennisOfficerOct 02 '24Proposed Sale43.213,104134,126Oct 02 04:44 PM
Leproust Emily M.OfficerOct 02 '24Proposed Sale43.2113,605587,880Oct 02 04:36 PM
Finn Patrick JohnOfficerOct 02 '24Proposed Sale43.216,865296,641Oct 02 04:33 PM
Cho DennisSee RemarksSep 20 '24Sale46.9423410,98478,393Sep 24 04:05 PM
TEAM - Atlassian Corporation - Stock Price Chart
TickerTEAM [NASD, NDX]
CompanyAtlassian Corporation
CountryUSA
IndustrySoftware - Application
Market Cap41.90BEPS (ttm)-1.16
P/E-EPS this Y7.35%
Forward P/E40.23EPS next Y27.35%
PEG-EPS past 5Y15.38%
P/S9.61EPS next 5Y27.95%
P/B40.65EPS Q/Q-230.31%
Dividend-Sales Q/Q20.50%
Insider Own39.95%Inst Own52.91%
Insider Trans-1.97%Inst Trans-4.54%
Short Float1.87%EarningsAug 01/a
Analyst Recom1.96Target Price207.45
Avg Volume1.82M52W Range135.29 - 258.69
Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cannon-Brookes MichaelCEO, Co-FounderOct 01 '24Sale159.817,9481,270,159500,724Oct 02 05:00 PM
Farquhar ScottDirectorOct 01 '24Sale159.817,9481,270,159500,724Oct 02 05:00 PM
Cannon-Brookes MichaelCEO, Co-FounderSep 30 '24Sale159.477,9481,267,4290Oct 01 04:15 PM
Farquhar ScottDirectorSep 30 '24Sale159.467,9481,267,4280Oct 01 04:14 PM
Cannon-Brookes MichaelCEO, Co-FounderSep 27 '24Sale161.307,9481,281,9967,948Sep 30 06:03 PM
MRVL - Marvell Technology Inc - Stock Price Chart
TickerMRVL [NASD, NDX]
CompanyMarvell Technology Inc
CountryUSA
IndustrySemiconductors
Market Cap63.26BEPS (ttm)-1.12
P/E-EPS this Y-3.15%
Forward P/E29.07EPS next Y71.80%
PEG-EPS past 5Y-29.04%
P/S11.98EPS next 5Y21.09%
P/B4.45EPS Q/Q7.34%
Dividend0.33%Sales Q/Q-5.07%
Insider Own1.30%Inst Own87.27%
Insider Trans-2.13%Inst Trans0.47%
Short Float2.22%EarningsAug 29/a
Analyst Recom1.21Target Price92.59
Avg Volume11.42M52W Range46.07 - 85.76
Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Casper MarkEVP & Chief Legal OfficerOct 01 '24Sale70.832,500177,07522,494Oct 02 04:59 PM
MARK CASPEROfficerOct 01 '24Proposed Sale72.122,500180,300Oct 01 04:29 PM
MURPHY MATTHEW JChairman of the Board and CEOSep 16 '24Sale73.296,000439,740208,915Sep 17 07:06 PM
Meintjes Willem AChief Financial OfficerSep 16 '24Sale73.871,500110,805111,753Sep 17 06:49 PM
Tamer FordDirectorSep 15 '24Option Exercise0.004,354049,327Sep 17 06:47 PM
W - Wayfair Inc - Stock Price Chart
TickerW [NYSE]
CompanyWayfair Inc
CountryUSA
IndustryInternet Retail
Market Cap6.48BEPS (ttm)-5.29
P/E-EPS this Y156.09%
Forward P/E34.78EPS next Y138.09%
PEG-EPS past 5Y-2.82%
P/S0.54EPS next 5Y-
P/B-EPS Q/Q16.17%
Dividend-Sales Q/Q-1.70%
Insider Own27.92%Inst Own89.55%
Insider Trans-0.55%Inst Trans-1.33%
Short Float23.58%EarningsAug 01/b
Analyst Recom2.05Target Price62.93
Avg Volume4.33M52W Range38.02 - 76.18
Wayfair, Inc. engages in an online home furnishing store. It operates through the U.S. and International segments. The U.S. segment consists of amounts earned through product sales through the company's five distinct sites in the U.S. and through websites operated by third parties in the U.S. The International segment is composed of earnings through product sales in international sites. The company was founded by Steven K. Conine and Niraj S. Shah in May 2002 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tan FionaOfficerOct 02 '24Proposed Sale53.0610,040532,759Oct 02 04:58 PM
Gulliver KateOfficerOct 02 '24Proposed Sale53.067,330388,894Oct 02 04:50 PM
Netzer ThomasOfficerOct 02 '24Proposed Sale53.068,435447,556Oct 02 04:42 PM
Blotner JonOfficerOct 02 '24Proposed Sale52.396,055317,226Oct 02 04:25 PM
Netzer ThomasChief Operating OfficerSep 17 '24Sale49.421,01149,964151,802Sep 18 06:24 PM
GILD - Gilead Sciences, Inc. - Stock Price Chart
TickerGILD [NASD, NDX, S&P 500]
CompanyGilead Sciences, Inc.
CountryUSA
IndustryDrug Manufacturers - General
Market Cap104.83BEPS (ttm)0.82
P/E102.91EPS this Y-43.63%
Forward P/E11.69EPS next Y90.08%
PEG17.21EPS past 5Y1.55%
P/S3.77EPS next 5Y5.98%
P/B5.74EPS Q/Q55.31%
Dividend3.65%Sales Q/Q5.46%
Insider Own0.21%Inst Own84.91%
Insider Trans-2.59%Inst Trans0.85%
Short Float1.61%EarningsAug 08/a
Analyst Recom2.17Target Price84.59
Avg Volume6.55M52W Range62.07 - 87.86
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Parsey MerdadChief Medical OfficerOct 01 '24Sale83.832,000167,660100,189Oct 02 04:58 PM
MERDAD V PARSEYOfficerOct 01 '24Proposed Sale83.832,000167,660Oct 01 04:27 PM
Parsey MerdadChief Medical OfficerSep 12 '24Option Exercise57.9225,0001,448,000123,435Sep 13 07:07 PM
Parsey MerdadChief Medical OfficerSep 12 '24Sale84.5021,2461,795,287102,189Sep 13 07:07 PM
Mercier JohannaChief Commercial OfficerSep 12 '24Sale83.7829,3572,459,57778,127Sep 13 05:08 PM
QCOM - Qualcomm, Inc. - Stock Price Chart
TickerQCOM [NASD, NDX, S&P 500]
CompanyQualcomm, Inc.
CountryUSA
IndustrySemiconductors
Market Cap187.82BEPS (ttm)7.71
P/E21.85EPS this Y19.25%
Forward P/E15.10EPS next Y11.10%
PEG1.73EPS past 5Y-
P/S5.03EPS next 5Y12.63%
P/B7.63EPS Q/Q17.04%
Dividend2.00%Sales Q/Q11.15%
Insider Own0.15%Inst Own77.90%
Insider Trans-5.71%Inst Trans-0.30%
Short Float2.14%EarningsJul 31/a
Analyst Recom1.97Target Price218.35
Avg Volume8.94M52W Range104.33 - 230.63
QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
THOMPSON JAMES HChief Technology OfficerOct 01 '24Option Exercise0.009,5750222,939Oct 02 04:56 PM
THOMPSON JAMES HChief Technology OfficerOct 01 '24Sale169.808,0001,358,400213,364Oct 02 04:56 PM
ROGERS ALEXANDER HPresident QTL & Global AffairsOct 01 '24Option Exercise0.005,319037,190Oct 02 04:55 PM
ROGERS ALEXANDER HPresident QTL & Global AffairsOct 02 '24Sale166.153,245539,15732,231Oct 02 04:55 PM
Palkhiwala Akash J.CFO & COOOct 01 '24Option Exercise0.005,107056,544Oct 02 04:55 PM
GOOGL - Alphabet Inc - Stock Price Chart
TickerGOOGL [NASD, NDX, S&P 500]
CompanyAlphabet Inc
CountryUSA
IndustryInternet Content & Information
Market Cap2029.55BEPS (ttm)6.97
P/E23.65EPS this Y31.76%
Forward P/E19.01EPS next Y13.52%
PEG1.15EPS past 5Y21.56%
P/S6.19EPS next 5Y20.50%
P/B6.75EPS Q/Q31.36%
Dividend0.23%Sales Q/Q13.46%
Insider Own52.52%Inst Own37.99%
Insider Trans-0.01%Inst Trans-0.22%
Short Float1.36%EarningsJul 23/a
Analyst Recom1.58Target Price202.75
Avg Volume25.35M52W Range120.21 - 191.75
Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pichai SundarChief Executive OfficerOct 02 '24Sale167.0722,5003,759,0832,129,306Oct 02 04:56 PM
O'Toole Amie ThuenerVP, Chief Accounting OfficerOct 01 '24Sale168.841,367230,80429,183Oct 02 04:31 PM
SUNDAR PICHAIDirectorOct 02 '24Proposed Sale168.4222,5003,789,450Oct 02 04:19 PM
PICHAI FAMILY FOUNDATION DirectorOct 02 '24Proposed Sale168.424,000673,680Oct 02 04:18 PM
WALKER JOHN KENTPresident, Global Affairs, CLOSep 27 '24Sale165.4716,8022,780,29443,999Sep 30 06:36 PM
12345678910